Delivery Order SPE2DB20D3103-SPE2DB21FQ4T5

Award Date 9/27/21
Potential Completion Date 9/28/21
Potential Value $1.8K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,508.27 Delivery Order is for the supply of Rizatriptan 10 mg Orally Disintegrating Tablets (ODTs), a medication used to treat migraine headaches. The contract has an ultimate completion date of May 3, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This federal contract award, valued at $15,260.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of rizatriptan 10 mg ODT UD 18s, a prescription migraine medication. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,322.72 firm fixed-price contract is for the supply of Rizatriptan 10 mg Orally Disintegrating Tablets, a medication used to treat migraine headaches. The contract has an ultimate completion date of May 10, 2023. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,896.14 firm fixed-price delivery order is for the supply of 4560678275 units of Rizatriptan 10 mg tablets, an acute migraine medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC, which runs through...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical distribution company. The $2,320.18 contract is for the delivery of 4,563,966,595 units of rizatriptan 10 mg orally disintegrating tablets, a migraine medication, to support military treatment programs and facilities. The award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, worth $2,418.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order, is for the supply of Rizatriptan 5 mg orally disintegrating tablets. It is a firm-fixed-price contract with a performance period through May 19, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This federal contract award, valued at $1,248.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Rizatriptan 10 mg orally disintegrating tablets (ODT). The award is a firm-fixed-price delivery order with an ultimate completion date of May 15, 2023. The contract is not associated with a set-aside program. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,184.82 firm fixed-price delivery order is for the supply of 18 units of the drug Rizatriptan 10 mg Orally Disintegrating Tablets. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Rizatriptan 10 mg oral disintegrating tablets in packs of 18. The total value of this award is $1,606.04, and it has an ultimate completion date of July 20, 2023. The contract is not designated with a set-aside requirement, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Rizatriptan 10 mg tablets, a medication used to treat migraines. The contract has a ceiling value of $1,004.38 and is a firm fixed-price, indefinite delivery vehicle with a completion date of March 11, 2025. The contract does not have a set-aside designation, indicating open...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB21FQ4T5
    Delivery Order

This federal contract award, valued at $1,826.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,554,932,696 units of Rizatriptan 5 mg Orally Disintegrating Tablets (ODT), a medication used to treat migraine headaches.

The contract is a Delivery Order (DO) under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.

The contract award did not have a set-aside designation, indicating it was competed on an open market basis. Amerisourcebergen, as a major pharmaceutical distributor, has a strong track record of supporting federal healthcare programs, particularly within the Department of Defense and Department of Veterans Affairs.

Generated 2/27/25, 11:35 AM